Intravenous Lignocaine vs Placebo

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 20, 2017

Primary Completion Date

July 20, 2018

Study Completion Date

July 20, 2018

Conditions
Hemodynamic Stability Post Intubation in Laryngoscopy Surgery
Interventions
DRUG

iv Lignocaine vs placebo

Lignocaine is available in an ampule of 10 ml containing 20 mg/ml of lignocaine or 2%, Lignocaine will be given in dose of 1.5 mg/kg I/V

Trial Locations (1)

75500

The Indus Hospital, Karachi

All Listed Sponsors
lead

Indus Hospital and Health Network

OTHER

NCT03787069 - Intravenous Lignocaine vs Placebo | Biotech Hunter | Biotech Hunter